Literature DB >> 21059831

The analysis of competing events like cause-specific mortality--beware of the Kaplan-Meier method.

Marion Verduijn1, Diana C Grootendorst, Friedo W Dekker, Kitty J Jager, Saskia le Cessie.   

Abstract

Kaplan-Meier analysis is a popular method used for analysing time-to-event data. In case of competing event analyses such as that of cardiovascular and non-cardiovascular mortality, however, the Kaplan-Meier method profoundly overestimates the cumulative mortality probabilities for each of the separate causes of death. This article provides an introduction to the problem of competing events in Kaplan-Meier analysis. It explains cumulative incidence competing risk analysis and demonstrates on a cohort of elderly dialysis patients that, in contrast to the Kaplan-Meier method, application of this method yields unbiased estimates of the cumulative probabilities for cause-specific mortality.

Entities:  

Mesh:

Year:  2010        PMID: 21059831     DOI: 10.1093/ndt/gfq661

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  40 in total

Review 1.  Integration of PKPD relationships into benefit-risk analysis.

Authors:  Francesco Bellanti; Rob C van Wijk; Meindert Danhof; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2015-07-29       Impact factor: 4.335

2.  Methodologic Issues When Estimating Risks in Pharmacoepidemiology.

Authors:  Jessie K Edwards; Laura L Hester; Mugdha Gokhale; Catherine R Lesko
Journal:  Curr Epidemiol Rep       Date:  2016-09-13

3.  Validity of eleven prognostic scores with respect to intra- and extrahepatic recurrence of hepatocellular carcinoma after liver transplantation.

Authors:  A Bauschke; A Altendorf-Hofmann; H Kissler; A Koch; C Malessa; U Settmacher
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-28       Impact factor: 4.553

4.  High rates of mortality and technique failure in peritoneal dialysis patients after critical illness.

Authors:  Ayaz Khan; Claudio Rigatto; Mauro Verrelli; Paul Komenda; Julie Mojica; Dan Roberts; Manish M Sood
Journal:  Perit Dial Int       Date:  2011-06-30       Impact factor: 1.756

5.  Comparison of Low-, Moderate-, and High-Molecular-Weight Hyaluronic Acid Injections in Delaying Time to Knee Surgery.

Authors:  Anand R Shewale; Charles L Barnes; Lori A Fischbach; Songthip T Ounpraseuth; Jacob T Painter; Bradley C Martin
Journal:  J Arthroplasty       Date:  2017-05-02       Impact factor: 4.757

6.  Plasma NT-proBNP as predictor of change in functional status, cardiovascular morbidity and mortality in the oldest old: the Leiden 85-plus study.

Authors:  Petra G van Peet; Anton J M de Craen; Jacobijn Gussekloo; Wouter de Ruijter
Journal:  Age (Dordr)       Date:  2014-05-08

7.  The Association of Effluent Ca125 with Peritoneal Dialysis Technique Failure.

Authors:  Deirisa Lopes Barreto; Tiny Hoekstra; Nynke Halbesma; Martijn Leegte; Elisabeth W Boeschoten; Friedo W Dekker; Raymond T Krediet
Journal:  Perit Dial Int       Date:  2015-07-07       Impact factor: 1.756

8.  The clinical prognostic value of molecular intrinsic tumor subtypes in older breast cancer patients: A FOCUS study analysis.

Authors:  Charla C Engels; Mandy Kiderlen; Esther Bastiaannet; Antien L Mooyaart; Ronald van Vlierberghe; Vincent T H B M Smit; Peter J K Kuppen; Cornelis J H van de Velde; G J Liefers
Journal:  Mol Oncol       Date:  2015-11-24       Impact factor: 6.603

9.  Timing and outcome of renal replacement therapy in patients with congenital malformations of the kidney and urinary tract.

Authors:  Elke Wühl; Karlijn J van Stralen; Enrico Verrina; Anna Bjerre; Christoph Wanner; James Goya Heaf; Oscar Zurriaga; Andries Hoitsma; Patrick Niaudet; Runolfur Palsson; Pietro Ravani; Kitty J Jager; Franz Schaefer
Journal:  Clin J Am Soc Nephrol       Date:  2012-10-18       Impact factor: 8.237

10.  Vascular disease, ESRD, and death: interpreting competing risk analyses.

Authors:  Morgan E Grams; Josef Coresh; Dorry L Segev; Lauren M Kucirka; Hocine Tighiouart; Mark J Sarnak
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-02       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.